申请人:Ciba-Geigy Corporation
公开号:US04160837A1
公开(公告)日:1979-07-10
The present invention provides new derivatives of perhydro-aza-heterocycles of the formula ##STR1## in which X is the oxo radical or hydrogen and the radical OR.sub.1, in which R.sub.1 is hydrogen or a substituted or unsubstituted aliphatic hydrocarbon radical, a substituted or unsubstituted araliphatic hydrocarbon radical or a substituted or unsubstituted aromatic hydrocarbon radical or an acyl radical, R.sub.2 is hydrogen or a substituted or unsubstituted aliphatic hydrocarbon radical, Y is oxygen or sulphur, n.sub.1 and n.sub.2 each are values of 1 to 3, n.sub.1 +n.sub.2 being at most four, and Ar is a substituted or unsubstituted aromatic hydrocarbon radical, and the acid addition salts, in particular the pharmaceutically acceptable acid addition salts thereof. These new substances possess valuable pharmacological properties, in particular antidepressant activity, and can be used for the treatment of mental depressions. Specific embodiments are trans- and cis-3-hydroxy-4-(3,4-dimethyl-phenoxy)-piperidine, trans- and cis-3-hydroxy-4-(2,3-dimethyl-phenoxy)-piperidine, their 1-methyl derivatives and the pharmaceutically acceptable salts of these substances.
本发明提供了新的perhydro-aza-杂环衍生物,化学式如下:其中X为氧化物基团或氢,基团OR.sub.1中R.sub.1为氢或取代或未取代的脂肪烃基团、取代或未取代的芳基脂肪烃基团或取代或未取代的芳基烃基团或酰基,R.sub.2为氢或取代或未取代的脂肪烃基团,Y为氧或硫,n.sub.1和n.sub.2各自为1至3的值,n.sub.1 +n.sub.2最多为四,Ar为取代或未取代的芳基烃基团,以及其酸盐加合物,特别是其中药学上可接受的酸盐。这些新物质具有有价值的药理特性,特别是抗抑郁活性,并可用于治疗精神抑郁症。具体实施例包括反式和顺式3-羟基-4-(3,4-二甲基苯氧基)-哌啶、反式和顺式3-羟基-4-(2,3-二甲基苯氧基)-哌啶,它们的1-甲基衍生物和这些物质的药学上可接受的盐。